Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSGM Biosig Technologies	$5.18 +3.8%	$5.96	$0.23 ▼ $14.11	$156.78M	1.65	875,220 shs	508,600 shs
LNSR LENSAR	$12.90 +3.4%	$12.85	$3.80 ▼ $17.31	$148.83M	0.5	56,653 shs	60,540 shs
RBOT Vicarious Surgical	$6.69 +4.8%	$8.57	$5.00 ▼ $19.00	$39.97M	1.41	39,388 shs	40,280 shs
RCEL Avita Medical	$4.88 +2.7%	$5.36	$3.60 ▼ $14.16	$126.44M	1.63	461,868 shs	226,439 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSGM Biosig Technologies	+3.81%	+4.23%	-6.50%	-1.89%	+1,077.27%
LNSR LENSAR	+3.45%	+1.98%	-1.98%	-4.87%	+187.95%
RBOT Vicarious Surgical	+4.21%	-1.69%	-44.48%	+0.15%	-3.81%
RCEL Avita Medical	+2.74%	-13.32%	-22.04%	-22.29%	-47.13%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BSGM Biosig Technologies	1.8623 of 5 stars	3.5	0.0	0.8	1.7	0.6
LNSR LENSAR	0.9145 of 5 stars	2.0	1.0	2.2	2.5	0.0
RBOT Vicarious Surgical	0.6602 of 5 stars	1.0	2.0	1.5	2.5	0.6
RCEL Avita Medical	1.417 of 5 stars	3.2	0.0	1.6	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSGM Biosig Technologies	3.00	Buy	$10.00	93.05% Upside
LNSR LENSAR	2.00	Hold	$15.00	16.28% Upside
RBOT Vicarious Surgical	2.00	Hold	$7.00	4.71% Upside
RCEL Avita Medical	2.40	Hold	$12.40	154.10% Upside

Current Analyst Ratings Breakdown

Latest RBOT, BSGM, LNSR, and RCEL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	RBOT Vicarious Surgical	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.50 ➝ $7.00
8/11/2025	RCEL Avita Medical	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$14.00 ➝ $8.00
8/8/2025	RCEL Avita Medical	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$19.00 ➝ $18.00
8/8/2025	RCEL Avita Medical	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Neutral ➝ Sell	$3.00
6/6/2025	BSGM Biosig Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$2.50 ➝ $10.00
6/6/2025	RCEL Avita Medical	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$19.00

(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSGM Biosig Technologies	$40K	4,068.89	N/A	N/A	($0.11) per share	-47.09
LNSR LENSAR	$58.36M	2.64	N/A	N/A	($1.93) per share	-6.68
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	$3.89 per share	N/A
RCEL Avita Medical	$64.25M	2.02	N/A	N/A	($0.48) per share	-10.17

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSGM Biosig Technologies	-$10.33M	N/A	0.00	N/A	N/A	N/A	-10,930.60%	-90.03%	N/A
LNSR LENSAR	-$31.40M	-$4.21	N/A	∞	N/A	-84.49%	-737.30%	-72.60%	11/6/2025 (Estimated)
RBOT Vicarious Surgical	-$63.22M	-$10.09	N/A	N/A	N/A	N/A	-148.14%	-98.07%	11/11/2025 (Estimated)
RCEL Avita Medical	-$61.85M	-$1.97	N/A	N/A	N/A	-68.87%	-632.62%	-71.52%	11/6/2025 (Estimated)

Latest RBOT, BSGM, LNSR, and RCEL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/15/2025	Q2 2025	BSGM Biosig Technologies	-$0.04	-$0.74	-$0.70	-$0.74	N/A	N/A
8/12/2025	Q2 2025	RBOT Vicarious Surgical	-$2.61	-$2.23	+$0.38	-$2.23	N/A	N/A
8/7/2025	Q2 2025	LNSR LENSAR	-$0.0750	-$0.15	-$0.0750	-$0.15	$16.55 million	$11.36 million
8/7/2025	Q2 2025	RCEL Avita Medical	-$0.26	-$0.38	-$0.12	-$0.38	$34.27 million	$18.42 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSGM Biosig Technologies	N/A	N/A	N/A	N/A	N/A
LNSR LENSAR	N/A	N/A	N/A	N/A	N/A
RBOT Vicarious Surgical	N/A	N/A	N/A	N/A	N/A
RCEL Avita Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSGM Biosig Technologies	N/A	0.03	2.37
LNSR LENSAR	N/A	1.52	0.88
RBOT Vicarious Surgical	N/A	5.11	5.11
RCEL Avita Medical	9.39	0.58	0.46

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSGM Biosig Technologies	7.16%
LNSR LENSAR	40.15%
RBOT Vicarious Surgical	47.27%
RCEL Avita Medical	27.66%

Insider Ownership

Company	Insider Ownership
BSGM Biosig Technologies	24.80%
LNSR LENSAR	38.52%
RBOT Vicarious Surgical	11.99%
RCEL Avita Medical	2.80%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSGM Biosig Technologies	50	31.42 million	23.63 million	No Data
LNSR LENSAR	110	11.94 million	7.34 million	Optionable
RBOT Vicarious Surgical	210	5.93 million	5.22 million	No Data
RCEL Avita Medical	130	26.62 million	25.87 million	Optionable

RBOT, BSGM, LNSR, and RCEL Headlines

Recent News About These Companies

Kirby McInerney LLP Announces Investigation Against AVITA Medical, Inc. on Behalf of Investors

August 22 at 5:52 PM | globenewswire.com

INVESTOR ALERT: Investigation of AVITA Medical, Inc. (RCEL) Announced by Holzer & Holzer, LLC

August 22 at 12:04 PM | globenewswire.com

AVITA Medical, Inc. (RCEL) Investors Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

August 21 at 10:51 PM | tmcnet.com

AVITA Medical Announces September Investor Conference Participation

August 21 at 4:05 PM | globenewswire.com

Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

August 21 at 3:00 PM | businesswire.com

AVITA Medical, Inc. (RCEL) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

August 21 at 12:35 PM | businesswire.com

Robert Mcnamara Acquires 10,000 Shares of Avita Medical (NASDAQ:RCEL) Stock

August 21 at 8:54 AM | insidertrades.com

Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced - Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

August 20 at 9:38 PM | tmcnet.com

Securities Fraud Investigation Into AVITA Medical, Inc. (RCEL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

August 20 at 5:39 PM | businesswire.com

Avita Medical Announces $15M Equity Placement Agreement

August 19, 2025 | msn.com

Cantor Fitzgerald Expects Reduced Earnings for Avita Medical

August 17, 2025 | marketbeat.com

Cantor Fitzgerald Forecasts Lower Earnings for Avita Medical

August 17, 2025 | americanbankingnews.com

Lake Street Capital Lowers Avita Medical (NASDAQ:RCEL) Price Target to $8.00

August 14, 2025 | americanbankingnews.com

Avita Medical Raises $15M in Private Placement

August 13, 2025 | msn.com

Analysts Are More Bearish On AVITA Medical, Inc. (NASDAQ:RCEL) Than They Used To Be

August 13, 2025 | finance.yahoo.com

Avita Medical completes Australian equity raise

August 13, 2025 | msn.com

AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2025 Earnings Call Transcript

August 13, 2025 | msn.com

Avita Medical’s Earnings Call: Growth Amid Challenges

August 13, 2025 | msn.com

Lake Street Capital Issues Pessimistic Forecast for Avita Medical (NASDAQ:RCEL) Stock Price

August 12, 2025 | marketbeat.com

AVITA Medical Successfully Completes Australian Equity Raise

August 12, 2025 | globenewswire.com

Brokerages Set Avita Medical Inc. (NASDAQ:RCEL) PT at $13.60

August 12, 2025 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RBOT, BSGM, LNSR, and RCEL Company Descriptions

Biosig Technologies NASDAQ:BSGM

$5.18 +0.19 (+3.81%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$5.20 +0.02 (+0.29%)

As of 08/22/2025 07:57 PM Eastern

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

LENSAR NASDAQ:LNSR

$12.90 +0.43 (+3.45%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$12.90 0.00 (0.00%)

As of 08/22/2025 04:10 PM Eastern

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Vicarious Surgical NYSE:RBOT

$6.68 +0.31 (+4.78%)

Closing price 08/22/2025 03:58 PM Eastern

Extended Trading

$6.74 +0.05 (+0.75%)

As of 08/22/2025 07:37 PM Eastern

Vicarious Surgical Inc. operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

Avita Medical NASDAQ:RCEL

$4.88 +0.13 (+2.74%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$4.88 0.00 (0.00%)

As of 08/22/2025 07:29 PM Eastern

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time